Breaking News Instant updates and real-time market news.

NVS

Novartis

$93.09 /

-0.92 (-0.98%)

12:34
06/18/21
06/18
12:34
06/18/21
12:34

Novartis reports data from completed two-copy cohort of Phase 3 SPR1NT trial

Novartis announced data it said reinforces the "transformational benefit of Zolgensma" gene therapy for spinal muscular atrophy, or SMA. New late-breaker data from the completed two-copy cohort of the Phase 3 SPR1NT clinical trial demonstrate age-appropriate milestone development in presymptomatic children with SMA without respiratory or nutritional support of any kind, and with no serious, treatment-related adverse events, the company said. The completed Phase 3 STR1VE-EU trial demonstrated rapid improvements in motor function following treatment with Zolgensma, and the majority of patients achieved motor milestones not observed in the natural history of SMA Type 1. Safety remained consistent with previously reported data. All children treated presymptomatically in the SPR1NT two-copy cohort achieved event-free survival, were independent of respiratory and nutritional support and met the primary endpoint of sitting independently for greater than or equal to30 seconds, including 11/14 who achieved this milestone within the World Health Organization window of normal development. A majority of patients went on to stand independently, 11/14, and walk independently, 9/14, most within the typical range of normal development. Among symptomatic children with SMA Type 1 treated in the STR1VE-EU trial, including patients with more severe disease at baseline, the majority of children, 82%, achieved developmental motor milestones not observed in the natural history of SMA Type 1, including 16 children, or 49%, who sat without support for greater than or equal to30 seconds. The data will be presented at the European Academy for Neurology Virtual Congress 2021.

NVS Novartis
$93.09 /

-0.92 (-0.98%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS

TODAY'S FREE FLY STORIES

Hot Stocks
AbbVie reports Q2 adjusted gross margin 82.2%  07:47
07/30/21
07/30
07:47
07/30/21
07:47
ABBV

AbbVie

$118.89 /

+0.14 (+0.12%)

 
ShowHide Related Items >><<
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/02/21
Fly Intel: Top five analyst initiations
07/02/21 Daiwa
AbbVie initiated with an Outperform at Daiwa
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

Earnings
Uxin sees Q1 revenue RMB260M-RMB280M » 07:46
07/30/21
07/30
07:46
07/30/21
07:46
UXIN

Uxin

$3.75 /

+0.51 (+15.74%)

Non-GAAP adjusted loss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UXIN Uxin
$3.75 /

+0.51 (+15.74%)

UXIN Uxin
$3.75 /

+0.51 (+15.74%)

UXIN Uxin
$3.75 /

+0.51 (+15.74%)

UXIN Uxin
$3.75 /

+0.51 (+15.74%)

Recommendations
Edwards Lifesciences price target raised to $124 from $103 at Canaccord » 07:46
07/30/21
07/30
07:46
07/30/21
07:46
EW

Edwards Lifesciences

$111.76 /

+1.65 (+1.50%)

Canaccord analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

07:42 Today Jefferies
Edwards Lifesciences price target raised to $130 from $110 at Jefferies
07:12 Today Wells Fargo
Edwards Lifesciences price target raised to $115 from $93 at Wells Fargo
07:05 Today Deutsche Bank
Edwards Lifesciences price target raised to $113 from $84 at Deutsche Bank
05:21 Today Piper Sandler
Edwards Lifesciences price target raised to $123 from $120 at Piper Sandler
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

Recommendations
DexCom price target raised to $525 from $500 at Oppenheimer » 07:46
07/30/21
07/30
07:46
07/30/21
07:46
DXCM

DexCom

$456.17 /

-3.25 (-0.71%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

07:45 Today Canaccord
DexCom price target raised to $500 from $455 at Canaccord
07:39 Today Raymond James
DexCom price target raised to $515 from $466 at Raymond James
07:05 Today Baird
DexCom price target raised to $520 from $460 at Baird
05:24 Today Piper Sandler
DexCom price target raised to $550 from $500 at Piper Sandler
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

Recommendations
VSE Corp. price target raised to $65 from $61 at B. Riley » 07:45
07/30/21
07/30
07:45
07/30/21
07:45
VSEC

VSE Corp.

$50.82 /

-1.35 (-2.59%)

B. Riley analyst Jeff Van…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSEC VSE Corp.
$50.82 /

-1.35 (-2.59%)

VSEC VSE Corp.
$50.82 /

-1.35 (-2.59%)

05/05/21
Fly Intel: Top five analyst initiations
05/05/21 B. Riley
B. Riley starts VSE with Buy, says 'flying under the radar'
05/05/21 B. Riley
VSE Corp. initiated with a Buy at B. Riley
03/19/21 Canaccord
VSE Corp. price target raised to $52 from $48 at Canaccord
VSEC VSE Corp.
$50.82 /

-1.35 (-2.59%)

  • 29
    Jan
VSEC VSE Corp.
$50.82 /

-1.35 (-2.59%)

Earnings
Uxin reports Q4 EPS (RMB0.12) vs. (RMB2.28) last year » 07:45
07/30/21
07/30
07:45
07/30/21
07:45
UXIN

Uxin

$3.75 /

+0.51 (+15.74%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UXIN Uxin
$3.75 /

+0.51 (+15.74%)

UXIN Uxin
$3.75 /

+0.51 (+15.74%)

UXIN Uxin
$3.75 /

+0.51 (+15.74%)

Earnings
AbbVie raises FY21 adjusted EPS view to $12.52-$12.62 from $12.37-$12.57 » 07:45
07/30/21
07/30
07:45
07/30/21
07:45
ABBV

AbbVie

$118.89 /

+0.14 (+0.12%)

FY21 consensus $12.60.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/02/21
Fly Intel: Top five analyst initiations
07/02/21 Daiwa
AbbVie initiated with an Outperform at Daiwa
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

Recommendations
DexCom price target raised to $500 from $455 at Canaccord » 07:45
07/30/21
07/30
07:45
07/30/21
07:45
DXCM

DexCom

$456.17 /

-3.25 (-0.71%)

Canaccord analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

07:39 Today Raymond James
DexCom price target raised to $515 from $466 at Raymond James
07:05 Today Baird
DexCom price target raised to $520 from $460 at Baird
05:24 Today Piper Sandler
DexCom price target raised to $550 from $500 at Piper Sandler
07/21/21 Cowen
DexCom price target lowered to $525 from $540 at Cowen
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

Recommendations
Skyworks price target raised to $245 from $235 at B. Riley » 07:45
07/30/21
07/30
07:45
07/30/21
07:45
SWKS

Skyworks

$196.78 /

+4.58 (+2.38%)

B. Riley analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

06:52 Today Benchmark
Skyworks transferred with a Buy at Benchmark
06:43 Today Mizuho
Skyworks price target raised to $215 from $210 at Mizuho
07/28/21 KeyBanc
Apple results moderately positive for iPhone suppliers, says KeyBanc
07/15/21 WestPark Capital
Skyworks initiated with a Buy at WestPark Capital
SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

SWKS Skyworks
$196.78 /

+4.58 (+2.38%)

Syndicate
United Rentals files automatic mixed securities shelf  07:45
07/30/21
07/30
07:45
07/30/21
07:45
URI

United Rentals

$322.52 /

-4.68 (-1.43%)

 
ShowHide Related Items >><<
URI United Rentals
$322.52 /

-4.68 (-1.43%)

URI United Rentals
$322.52 /

-4.68 (-1.43%)

07/14/21 Barclays
United Rentals price target raised to $265 from $255 at Barclays
07/14/21 Deutsche Bank
United Rentals price target lowered to $342 from $360 at Deutsche Bank
06/25/21
Fly Intel: Top five analyst upgrades
06/25/21 UBS
United Rentals upgraded to Buy from Neutral at UBS
URI United Rentals
$322.52 /

-4.68 (-1.43%)

URI United Rentals
$322.52 /

-4.68 (-1.43%)

URI United Rentals
$322.52 /

-4.68 (-1.43%)

Earnings
AbbVie reports Q2 adjusted EPS $3.11, consensus $3.09 » 07:44
07/30/21
07/30
07:44
07/30/21
07:44
ABBV

AbbVie

$118.89 /

+0.14 (+0.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/02/21
Fly Intel: Top five analyst initiations
07/02/21 Daiwa
AbbVie initiated with an Outperform at Daiwa
ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

ABBV AbbVie
$118.89 /

+0.14 (+0.12%)

Recommendations
Industrial Logistics Property price target raised to $35 from $32 at B. Riley » 07:43
07/30/21
07/30
07:43
07/30/21
07:43
ILPT

Industrial Logistics Property Trust

$27.19 /

+0.18 (+0.67%)

B. Riley analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILPT Industrial Logistics Property Trust
$27.19 /

+0.18 (+0.67%)

06/22/21 RBC Capital
Industrial Logistics Property Trust price target raised to $26 from $22 at RBC Capital
06/15/21 B. Riley
Industrial Logistics Property Trust price target raised to $32 from $29 at B. Riley
04/28/21 B. Riley
Industrial Logistics price target raised to $29 from $28 at B. Riley
04/26/21 BTIG
Industrial Logistics Property Trust initiated with a Neutral at BTIG
ILPT Industrial Logistics Property Trust
$27.19 /

+0.18 (+0.67%)

Recommendations
Amazon.com remains a core large-cap holding, says Canaccord » 07:42
07/30/21
07/30
07:42
07/30/21
07:42
AMZN

Amazon.com

$3,599.22 /

-33.28 (-0.92%)

Canaccord analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

07:33 Today Raymond James
Amazon.com price target lowered to $3,900 from $4,125 at Raymond James
07:33 Today Stifel
Stifel keeps $4,400 price target on Amazon shares, says 'buy the dip'
07:24 Today Truist
Amazon.com price target lowered to $3,800 from $4,000 at Truist
07:00 Today Credit Suisse
Amazon.com price target lowered to $4,700 from $4,850 at Credit Suisse
AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

AMZN Amazon.com
$3,599.22 /

-33.28 (-0.92%)

Recommendations
Edwards Lifesciences price target raised to $130 from $110 at Jefferies » 07:42
07/30/21
07/30
07:42
07/30/21
07:42
EW

Edwards Lifesciences

$111.76 /

+1.65 (+1.50%)

Jefferies analyst Raj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

07:12 Today Wells Fargo
Edwards Lifesciences price target raised to $115 from $93 at Wells Fargo
07:05 Today Deutsche Bank
Edwards Lifesciences price target raised to $113 from $84 at Deutsche Bank
05:21 Today Piper Sandler
Edwards Lifesciences price target raised to $123 from $120 at Piper Sandler
07/27/21 Piper Sandler
Edwards Lifesciences price target raised to $120 from $105 at Piper Sandler
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

Hot Stocks
Ucommune International signs cooperation agreement for Beijing Financial Center » 07:42
07/30/21
07/30
07:42
07/30/21
07:42
UK

Ucommune International

$1.11 /

+0.03 (+2.78%)

Ucommune International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UK Ucommune International
$1.11 /

+0.03 (+2.78%)

Recommendations
Aspen Aerogels price target raised to $49 from $44 at B. Riley » 07:42
07/30/21
07/30
07:42
07/30/21
07:42
ASPN

Aspen Aerogels

$38.59 /

-0.78 (-1.98%)

B. Riley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

07:42 Today Canaccord
Aspen Aerogels price target raised to $45 from $36 at Canaccord
07/26/21 B. Riley
Aspen Aerogels price target raised to $44 from $40 at B. Riley
07/15/21 Seaport Global
Aspen Aerogels initiated with a Buy at Seaport Global
07/01/21 Canaccord
Aspen Aerogels price target raised to $36 from $32 at Canaccord
ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

Earnings
Bel Fuse reports Q2 EPS 61c, one est. 34c » 07:42
07/30/21
07/30
07:42
07/30/21
07:42
BELFA

Bel Fuse

$12.70 /

+0.05 (+0.40%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BELFA Bel Fuse
$12.70 /

+0.05 (+0.40%)

Recommendations
Aspen Aerogels price target raised to $45 from $36 at Canaccord » 07:42
07/30/21
07/30
07:42
07/30/21
07:42
ASPN

Aspen Aerogels

$38.59 /

-0.78 (-1.98%)

Canaccord analyst Jed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

07/26/21 B. Riley
Aspen Aerogels price target raised to $44 from $40 at B. Riley
07/15/21 Seaport Global
Aspen Aerogels initiated with a Buy at Seaport Global
07/01/21 Canaccord
Aspen Aerogels price target raised to $36 from $32 at Canaccord
07/01/21 B. Riley
Aspen Aerogels price target raised to $40 from $25 at B. Riley
ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

ASPN Aspen Aerogels
$38.59 /

-0.78 (-1.98%)

Earnings
Cboe Global Markets raises 2021 non-transaction revenue growth view to 15%-16% » 07:40
07/30/21
07/30
07:40
07/30/21
07:40
CBOE

Cboe Global Markets

$116.15 /

-0.47 (-0.40%)

Had previously expected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBOE Cboe Global Markets
$116.15 /

-0.47 (-0.40%)

CBOE Cboe Global Markets
$116.15 /

-0.47 (-0.40%)

07/12/21 Piper Sandler
Cboe Global Markets price target raised to $117 from $113 at Piper Sandler
07/07/21 UBS
Cboe Global Markets price target raised to $124 from $111 at UBS
06/24/21 Credit Suisse
Cboe Global Markets assumed with a Neutral at Credit Suisse
06/11/21 Morgan Stanley
Cboe Global Markets initiated with an Underweight at Morgan Stanley
CBOE Cboe Global Markets
$116.15 /

-0.47 (-0.40%)

CBOE Cboe Global Markets
$116.15 /

-0.47 (-0.40%)

CBOE Cboe Global Markets
$116.15 /

-0.47 (-0.40%)

CBOE Cboe Global Markets
$116.15 /

-0.47 (-0.40%)

Recommendations
Omnicell should be bought on post-earnings weakness, says Benchmark » 07:40
07/30/21
07/30
07:40
07/30/21
07:40
OMCL

Omnicell

$141.50 /

-6.92 (-4.66%)

Benchmark analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMCL Omnicell
$141.50 /

-6.92 (-4.66%)

OMCL Omnicell
$141.50 /

-6.92 (-4.66%)

07/27/21 BTIG
Omnicell price target raised to $175 from $165 at BTIG
06/23/21 Piper Sandler
Omnicell price target raised to $188 from $152 at Piper Sandler
06/09/21
Fly Intel: Top five analyst initiations
06/09/21 JPMorgan
Omnicell initiated with a Neutral at JPMorgan
OMCL Omnicell
$141.50 /

-6.92 (-4.66%)

OMCL Omnicell
$141.50 /

-6.92 (-4.66%)

Hot Stocks
Matthews announces continuation of stock repurchase program » 07:40
07/30/21
07/30
07:40
07/30/21
07:40
MATW

Matthews

$34.45 /

+0.35 (+1.03%)

Matthews International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MATW Matthews
$34.45 /

+0.35 (+1.03%)

Recommendations
DexCom price target raised to $515 from $466 at Raymond James » 07:39
07/30/21
07/30
07:39
07/30/21
07:39
DXCM

DexCom

$456.17 /

-3.25 (-0.71%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

07:05 Today Baird
DexCom price target raised to $520 from $460 at Baird
05:24 Today Piper Sandler
DexCom price target raised to $550 from $500 at Piper Sandler
07/21/21 Cowen
DexCom price target lowered to $525 from $540 at Cowen
07/01/21 Piper Sandler
DexCom settlement with Abbott could be lucrative, says Piper Sandler
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

Earnings
Cerner sees FY21 adjusted EPS approx. $3.25, consensus $3.22 » 07:38
07/30/21
07/30
07:38
07/30/21
07:38
CERN

Cerner

$78.49 /

-0.26 (-0.33%)

Sees revenue growth in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERN Cerner
$78.49 /

-0.26 (-0.33%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

04/29/21 JPMorgan
Cerner assumed with a Neutral at JPMorgan
02/16/21 Piper Sandler
Cerner price target raised to $85 from $84 at Piper Sandler
02/11/21 KeyBanc
Cerner price target raised to $90 from $82 at KeyBanc
02/11/21 Truist
Cerner price target raised to $82 from $72 at Truist
CERN Cerner
$78.49 /

-0.26 (-0.33%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

Recommendations
ConnectOne Bancorp price target raised to $40 from $35 at Raymond James » 07:37
07/30/21
07/30
07:37
07/30/21
07:37
CNOB

ConnectOne Bancorp

$26.46 /

+0.71 (+2.76%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNOB ConnectOne Bancorp
$26.46 /

+0.71 (+2.76%)

CNOB ConnectOne Bancorp
$26.46 /

+0.71 (+2.76%)

02/18/21 Seaport Global
ConnectOne Bancorp initiated with a Buy at Seaport Global
02/18/21 Seaport Global
ConnectOne Bancorp initiated with a Buy at Seaport Global
12/17/20 Piper Sandler
ConnectOne Bancorp initiated with an Overweight at Piper Sandler
CNOB ConnectOne Bancorp
$26.46 /

+0.71 (+2.76%)

Earnings
Cerner sees Q3 adjusted EPS growth 12%-15% y-o-y, consensus 82c » 07:37
07/30/21
07/30
07:37
07/30/21
07:37
CERN

Cerner

$78.49 /

-0.26 (-0.33%)

Sees Q3 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERN Cerner
$78.49 /

-0.26 (-0.33%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

04/29/21 JPMorgan
Cerner assumed with a Neutral at JPMorgan
02/16/21 Piper Sandler
Cerner price target raised to $85 from $84 at Piper Sandler
02/11/21 KeyBanc
Cerner price target raised to $90 from $82 at KeyBanc
02/11/21 Truist
Cerner price target raised to $82 from $72 at Truist
CERN Cerner
$78.49 /

-0.26 (-0.33%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

CERN Cerner
$78.49 /

-0.26 (-0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.